Pharmacological properties of physical exercise in the elderly

Current Pharmaceutical Design

Volumn 20, Issue 18, 2014, Pages 3019-3029

  Viña, Jose ^a   Borras, Consuelo ^a   Sanchis Gomar, Fabian ^a   Martinez Bello, Vladimir E ^a   Olaso Gonzalez, Gloria ^a   Gambini, Juan ^a   Ingles, Marta ^b   Gomez Cabrera, Mari Carmen ^a  

^a Instituto Universitario IVI INCLIVA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adaptation; Aging; Health; Inactivity; NF B; PGC 1 ; Training

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PSYCHOTROPIC AGENT;

ADAPTATION; AGED; AGING; ARTICLE; CELL FUNCTION; CELL PH; EXERCISE; EXERCISE INTENSITY; GERIATRIC PATIENT; HUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SARCOPENIA; SENESCENCE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TREATMENT CONTRAINDICATION; ALZHEIMER DISEASE; ANIMAL; KINESIOTHERAPY; LIFESTYLE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AGED; AGING; ALZHEIMER DISEASE; ANIMALS; EXERCISE; EXERCISE THERAPY; HUMANS; LIFE STYLE; MUSCLE, SKELETAL; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; SARCOPENIA; SIGNAL TRANSDUCTION;

EID: 84903717860     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113196660704     Document Type: Article

References (180)

1. Vina J, Sanchis-Gomar F, Martinez-Bello V, et al. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol 2012; 167: 1-12.
2. Adolph EF. Physiological adaptations: hypertrophies and superfunctions. Am Sci 1972; 60: 608-17.
3. Vina J, Borras C, Miquel J. Theories of ageing. IUBMB Life 2007; 59: 249-54.
4. Fries JF. Physical activity, the compression of morbidity, and the health of the elderly. J R Soc Med 1996; 89: 64-8.
5. Ji LL, Leeuwenburgh C, Leichtweis S, et al. Oxidative stress and aging. Role of exercise and its influences on antioxidant systems. Ann N Y Acad Sci 1998; 854: 102-17.
6. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006; 16 Suppl 1: 3-63.
7. Manini TM, Newman AB, Fielding R, et al. Effects of exercise on mobility in obese and nonobese older adults. Obesity (Silver Spring) 2010; 18: 1168-75.
8. Goetzl EJ. Is aging a drug target? FASEB J 2011; 25: 2509-11.
9. Nascher IL, Jacobi A. Geriatrics: the diseases of old age and their treatment including physiological old age, home and institutional care, and medico-legal relations. K. Paul, French, Trubner: [S.l.] 1919.
10. Kirkland JL, Peterson C. Healthspan, translation, and new outcomes for animal studies of aging. J Gerontol A Biol Sci Med Sci 2009; 64: 209-12.
11. Garcia-Valles R, Ibañez-Sania S, Sanchis-Gomar F, et al. Long Life Spontaneous Exercise Does Not Prolong Lifespan But Prevents Frailty In C57BL/6J. Healthspan Vs Lifespan. 7th Congress of the EUGMS. Revista Española de Geriatría y Gerontología (Espec Cong) 2011; 46: 224.
12. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980; 303: 130-5.
13. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985; 100: 126-31.
14. Pate RR, Pratt M, Blair SN, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-7.
15. Lyons AS, Petrucelli RJja. Medicine: an illustrated history. H. N. Abrams: New York 1978.
16. Speed C, Jaques R. High-performance sports medicine: an ancient but evolving field. Br J Sports Med 2010; 45: 81-3.
17. Fox SM, 3rd, Haskell WL. Physical activity and the prevention of coronary heart disease. Bull N Y Acad Med 1968; 44: 950-67.
18. Morris JN, Heady JA, Raffle PA, et al. Coronary heart-disease and physical activity of work. Lancet 1953; 265: 1053-7; contd.
19. Morris JN, Heady JA, Raffle PA, et al. Coronary heart-disease and physical activity of work. Lancet 1953; 265: 1111-20; concl.
20. Paffenbarger RS, Hale WE. Work activity and coronary heart mortality. N Engl J Med 1975; 292: 545-50.
21. Paffenbarger RS, Jr., Brand RJ, Sholtz RI, et al. Energy expenditure, cigarette smoking, and blood pressure level as related to death from specific diseases. Am J Epidemiol 1978; 108: 12-8.
22. Karvonen MJ, Klemola H, Virkajarvi J, et al. Longevity of endurance skiers. Med Sci Sports 1974; 6: 49-51.
23. Macera CA, Hootman JM, Sniezek JE. Major public health benefits of physical activity. Arthritis Rheum 2003; 49: 122-8.
24. Blair SN, Kohl HW, 3rd, Paffenbarger RS, Jr., et al. Physical fitness and all-cause mortality. A prospective study of healthy men and women. Jama 1989; 262: 2395-401.
25. Paffenbarger RS, Jr., Hyde RT, Wing AL, et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986; 314: 605-13.
26. Myers J, Kaykha A, George S, et al. Fitness versus physical activity patterns in predicting mortality in men. Am J Med 2004; 117: 912-8.
27. Bouchard C, Shephard RJ, Stephens T. Physical activity, fitness, and health: international proceedings and consensus statement: [Second International Consensus Symposium on Physical Activity, Fitness, and Health, held May 5 to May 9, 1992, in Toronto, Canada]. Human Kinetics Publishers: Champaign, Ill.; Leeds 1994.
28. Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. Cmaj 2006; 174: 801-9.
29. Vina J, Sanchis-Gomar F, Martinez-Bello V, et al. Exercise acts as a drug; the pharmacological benefits of exercise. Br J Pharmacol 2012; 167: 1-12.
30. Lee IM. Dose-response relation between physical activity and fitness: even a little is good; more is better. JAMA 2007; 297: 2137-9.
31. Beers MH, Fink A, Beck JC. Screening recommendations for the elderly. Am J Public Health 1991; 81: 1131-40.
32. Turnheim K. Drug dosage in the elderly. Is it rational? Drugs Aging 1998; 13: 357-79.
33. Blair SN, LaMonte MJ, Nichaman MZ. The evolution of physical activity recommendations: how much is enough? Am J Clin Nutr 2004; 79: 913S-920S.
34. Warburton DE, Nicol CW, Bredin SS. Prescribing exercise as preventive therapy. Cmaj 2006; 174: 961-74.
35. Church TS, Earnest CP, Skinner JS, et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. Jama 2007; 297: 2081-91.
36. Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 2011.
37. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1435-45.
38. Sanchis-Gomar F, Olaso-Gonzalez G, Corella D, et al. Increased average longevity among the "Tour de France" cyclists. Int J Sports Med 2011; 32: 644-7.
39. Shephard RJ. Absolute versus relative intensity of physical activity in a dose-response context. Med Sci Sports Exerc 2001; 33: S400-18; discussion S419-20.
40. Lepers R, Cattagni T. Do older athletes reach limits in their performance during marathon running? Age (Dordr) 2012; 34: 773-81.
41. Wannamethee SG, Shaper AG, Walker M. Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet 1998; 351: 1603-8.
42. Hakim AA, Petrovitch H, Burchfiel CM, et al. Effects of walking on mortality among nonsmoking retired men. N Engl J Med 1998; 338: 94-9.
43. WHO Global Recommendations on Physical Activity for Health 2010.
44. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-56.
45. Ensrud KE, Ewing SK, Cawthon PM, et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc 2009; 57: 492-8.
46. Lee DC, Artero EG, Sui X, et al. Mortality trends in the general population: the importance of cardiorespiratory fitness. J Psychopharmacol 2010; 24: 27-35.
47. Kujala UM. Born to be rich, physically active, fit and healthy? Scand J Med Sci Sports 2011; 20: 367.
48. Matsakas A, Narkar VA. Endurance exercise mimetics in skeletal muscle. Curr Sports Med Rep 2010; 9: 227-32.
49. Derbre F, Gomez-Cabrera MC, Nascimento AL, et al. Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1alpha to exercise training. Age (Dordr) 2012; 34: 669-79.
50. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769-75.
51. Gill TM, Gahbauer EA, Han L, et al. Trajectories of disability in the last year of life. N Engl J Med 2010; 362: 1173-80.
52. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 1984; 56: 831-8.
53. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-73.
54. Dunn AL, Trivedi MH, O'Neal HA. Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc 2001; 33: S587-97; discussion 609-10.
55. Neeper SA, Gomez-Pinilla F, Choi J, et al. Exercise and brain neurotrophins. Nature 1995; 373: 109.
56. Pareja-Galeano H, Brioche T, Sanchis-Gomar F, et al. [Effects of physical exercise on cognitive alterations and oxidative stress in an APP/PSN1 transgenic model of Alzheimer's disease]. Rev Esp Geriatr Gerontol 2012; 47: 198-204.
57. Neeper SA, Gomez-Pinilla F, Choi J, et al. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 1996; 726: 49-56.
58. Adlard PA, Perreau VM, Cotman CW. The exercise-induced expression of BDNF within the hippocampus varies across life-span. Neurobiol Aging 2005; 26: 511-20.
59. Poulton NP, Muir GD. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-parkinsonian rats. Exp Neurol 2005; 193: 181-97.
60. Kramer AF, Erickson KI, Colcombe SJ. Exercise, cognition, and the aging brain. J Appl Physiol 2006; 101: 1237-42.
61. Mandroukas K, Krotkiewski M, Hedberg M, et al. Physical training in obese women. Effects of muscle morphology, biochemistry and function. Eur J Appl Physiol Occup Physiol 1984; 52: 355-61.
62. Shephard RJ, Futcher R. Physical activity and cancer: how may protection be maximized? Crit Rev Oncog 1997; 8: 219-72.
63. Westerlind KC. Physical activity and cancer prevention--mechanisms. Med Sci Sports Exerc 2003; 35: 1834-40.
64. Vaynman S, Gomez-Pinilla F. Revenge of the "sit": how lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity. J Neurosci Res 2006; 84: 699-715.
65. Dishman RK, Berthoud HR, Booth FW, et al. Neurobiology of exercise. Obesity (Silver Spring) 2006; 14: 345-56.
66. van Praag H, Christie BR, Sejnowski TJ, et al. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci U S A 1999; 96: 13427-31.
67. Laurin D, Verreault R, Lindsay J, et al. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001; 58: 498-504.
68. Grealy MA, Johnson DA, Rushton SK. Improving cognitive function after brain injury: the use of exercise and virtual reality. Arch Phys Med Rehabil 1999; 80: 661-7.
69. Siuciak JA, Boylan C, Fritsche M, et al. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 1996; 710: 11-20.
70. Shirayama Y, Chen AC, Nakagawa S, et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22: 3251-61.
71. Vissing J, Andersen M, Diemer NH. Exercise-induced changes in local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 1996; 16: 729-36.
72. Daulatzai MA. Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease. J Alzheimers Dis 2010; 20: 355-67.
73. Mayeux R, Stern Y. Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med; 2.
74. Venturelli M, Scarsini R, Schena F. Six-month walking program changes cognitive and ADL performance in patients with Alzheimer. Am J Alzheimers Dis Other Demen 2011; 26: 381-8.
75. Blankevoort CG, van Heuvelen MJ, Boersma F, et al. Review of effects of physical activity on strength, balance, mobility and ADL performance in elderly subjects with dementia. Dement Geriatr Cogn Disord 2010; 30: 392-402.
76. Yaguez L, Shaw KN, Morris R, et al. The effects on cognitive functions of a movement-based intervention in patients with Alzheimer's type dementia: a pilot study. Int J Geriatr Psychiatry; 26: 173-81.
77. O'Callaghan RM, Griffin EW, Kelly AM. Long-term treadmill exposure protects against age-related neurodegenerative change in the rat hippocampus. Hippocampus 2009; 19: 1019-29.
78. Buchman AS, Bennett DA. Amyloid pathology in persons with "normal" cognition. Neurology 2012; 78: 228-9.
79. Norton MC, Dew J, Smith H, et al. Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: the Cache County study. J Am Geriatr Soc 2012; 60: 405-12.
80. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127: 990S-991S.
81. Cruz-Jentoft AJ, Landi F, Topinkova E, et al. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1-7.
82. Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15-to 83-year-old men. J Neurol Sci 1988; 84: 275-94.
83. Fiatarone MA, Marks EC, Ryan ND, et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 1990; 263: 3029-34.
84. Peterson MD, Rhea MR, Sen A, et al. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev 2010; 9: 226-37.
85. Steib S, Schoene D, Pfeifer K. Dose-response relationship of resistance training in older adults: a meta-analysis. Med Sci Sports Exerc 2010; 42: 902-14.
86. Coggan AR, Spina RJ, King DS, et al. Skeletal muscle adaptations to endurance training in 60-to 70-yr-old men and women. J Appl Physiol 1992; 72: 1780-6.
87. Balagopal P, Schimke JC, Ades P, et al. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab 2001; 280: E203-8.
88. Menshikova EV, Ritov VB, Fairfull L, et al. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci 2006; 61: 534-40.
89. Kahn SE, Larson VG, Beard JC, et al. Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging. Am J Physiol 1990; 258: E937-43.
90. Fujita S, Rasmussen BB, Cadenas JG, et al. Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling. Diabetes 2007; 56: 1615-22.
91. Marzetti E, Calvani R, Bernabei R, et al. Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty-a mini-review. Gerontology 2012; 58: 99-106.
92. Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008; 12: 433-50.
93. Abellan van Kan G, Andre E, Bischoff Ferrari HA, et al. Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging 2009; 13: 700-7.
94. Lemura LM, von Duvillard SP, Mookerjee S. The effects of physical training of functional capacity in adults. Ages 46 to 90: a metaanalysis. J Sports Med Phys Fitness 2000; 40: 1-10.
95. Hawkins S, Wiswell R. Rate and mechanism of maximal oxygen consumption decline with aging: implications for exercise training. Sports Med 2003; 33: 877-88.
96. Phillips SM. Resistance exercise: good for more than just Grandma and Grandpa's muscles. Appl Physiol Nutr Metab 2007; 32: 1198-205.
97. Visvanathan R, Chapman I. Preventing sarcopaenia in older people. Maturitas 2010; 66: 383-8.
98. Phillips SM, Tipton KD, Aarsland A, et al. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am J Physiol 1997; 273: E99-107.
99. Drummond MJ, Dreyer HC, Pennings B, et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol 2008; 104: 1452-61.
100. Phillips SM. Protein requirements and supplementation in strength sports. Nutrition 2004; 20: 689-95.
101. Martin Ginis KA, Latimer AE, Brawley LR, et al. Weight training to activities of daily living: helping older adults make a connection. Med Sci Sports Exerc 2006; 38: 116-21.
102. Vincent KR, Braith RW, Feldman RA, et al. Improved cardiorespiratory endurance following 6 months of resistance exercise in elderly men and women. Arch Intern Med 2002; 162: 673-8.
103. Frankel JE, Bean JF, Frontera WR. Exercise in the elderly: research and clinical practice. Clin Geriatr Med 2006; 22: 239-56; vii.
104. Jones TE, Stephenson KW, King JG, et al. Sarcopenia--mechanisms and treatments. J Geriatr Phys Ther 2009; 32: 83-9.
105. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Clarendon Press: Oxford 1985.
106. Davies KJ, Quintanilha AT, Brooks GA, et al. Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 1982; 107: 1198-205.
107. Ji LL. Exercise at old age: does it increase or alleviate oxidative stress? Ann N Y Acad Sci 2001; 928: 236-47.
108. Commoner B, Townsend J, Pake GE. Free radicals in biological materials. Nature 1954; 174: 689-91.
109. Dillard CJ, Litov RE, Tappel AL. Effects of dietary vitamin E, selenium, and polyunsaturated fats on in vivo lipid peroxidation in the rat as measured by pentane production. Lipids 1978; 13: 396-402.
110. Koren A, Schara M, Sentjurc M. EPR measurements of free radicals during tetanic contractions of frog skeletal muscle. Period Biol. 1980; 82: 399-401
111. Gomez-Cabrera MC, Pallardo FV, Sastre J, et al. Allopurinol and markers of muscle damage among participants in the Tour de France. Jama 2003; 289: 2503-4.
112. Gomez-Cabrera MC, Martinez A, Santangelo G, et al. Oxidative stress in marathon runners: interest of antioxidant supplementation. Br J Nutr 2006; 96 Suppl 1: S31-3.
113. Powers SK, Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 2008; 88: 1243-76.
114. Gomez-Cabrera MC, Vina J, Ji LL. Interplay of oxidants and antioxidants during exercise: implications for muscle health. Phys Sportsmed 2009; 37: 116-23.
115. Jackson MJ, Pye D, Palomero J. The production of reactive oxygen and nitrogen species by skeletal muscle. J Appl Physiol 2007; 102: 1664-70.
116. Gomez-Cabrera MC, Domenech E, Vina J. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radic Biol Med 2008; 44: 126-31.
117. Hellsten Y, Ahlborg G, Jensen-Urstad M, et al. Indication of in vivo xanthine oxidase activity in human skeletal muscle during exercise. Acta Physiol Scand 1988; 134: 159-60.
118. Stofan DA, Callahan LA, Di MA, et al. Modulation of release of reactive oxygen species by the contracting diaphragm. Am J Respir Crit Care Med 2000; 161: 891-8.
119. Harris CM, Sanders SA, Massey V. Role of the flavin midpoint potential and NAD binding in determining NAD versus oxygen reactivity of xanthine oxidoreductase. J Biol Chem 1999; 274: 4561-9.
120. Gomez-Cabrera MC, Borras C, Pallardo FV, et al. Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats. J Physiol 2005; 567: 113-20.
121. Gomez-Cabrera MC, Close GL, Kayani A, et al. Effect of xanthine oxidase-generated extracellular superoxide on skeletal muscle force generation. American Journal of Physiology:Regulatory, Integrative and Comparative Physiology 2009; Under review.
122. Harman D. Aging: a theory based on free radical and ratiation chemistry. J. Gerontol 1956; 11: 298-300.
123. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
124. Miquel J, Economos AC, Fleming J, et al. Mitochondrial role in cell aging. Exp Gerontol 1980; 15: 575-91.
125. Yang W, Hekimi S. A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans. PLoS Biol; 8: e1000556.
126. Sohal RS, Orr WC. Relationship between antioxidants, prooxidants, and the aging process. Ann N Y Acad Sci 1992; 663: 74-84.
127. García de la Asunción J, Millan A, Pla R, et al. Mitochondiral glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J. 1996; 10: 333-338.
128. Fulle S, Protasi F, Di Tano G, et al. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol 2004; 39: 17-24.
129. Ji LL, Dillon D, Wu E. Alteration of antioxidant enzymes with aging in rat skeletal muscle and liver. Am J Physiol 1990; 258: R918-23.
130. Luhtala TA, Roecker EB, Pugh T, et al. Dietary restriction attenuates age-related increases in rat skeletal muscle antioxidant enzyme activities. J Gerontol 1994; 49: B231-8.
131. Hollander J, Bejma J, Ookawara T, et al. Superoxide dismutase gene expression in skeletal muscle: fiber-specific effect of age. Mech Ageing Dev 2000; 116: 33-45.
132. Oh-ishi S, Toshinai K, Kizaki T, et al. Effects of aging and/or training on antioxidant enzyme system in diaphragm of mice. Respir Physiol 1996; 105: 195-202.
133. Bejma J, Ji L. Aging and acute exercise inhance free radical generation in rat skeletal muscle. J. Appl. Physiol. 1999; 87: 465-470.
134. Leeuwenburgh C, Fiebig R, Chandwaney R, et al. Aging and exercise training in skeletal muscle: responses of glutathione and antioxidant enzyme systems. Am. J. Physiol. 1994; 267: R439-45.
135. Fiebig R, Leeuwenburgh C, Gore M, et al. The interactive effects of aging and training on myocardial antioxidant enzymes and oxidative stress. Age 1996; 19: 83-89.
136. Sakamoto K, Goodyear LJ. Invited review: intracellular signaling in contracting skeletal muscle. J Appl Physiol 2002; 93: 369-83.
137. Ji LL, Gomez-Cabrera MC, Steinhafel N, et al. Acute exercise activates nuclear factor (NF)-kappaB signaling pathway in rat skeletal muscle. Faseb J 2004; 18: 1499-506.
138. Goodyear LJ, Chang PY, Sherwood DJ, et al. Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol 1996; 271: E403-8.
139. Gomez-Cabrera MC, Borras C, Pallardo FV, et al. Decreasing Xanthine Oxidase Mediated Oxidative Stress Prevents Useful Cellular Adaptations to Exercise in Rats. J Physiol 2005.
140. Gambini J, Gomez-Cabrera MC, Borras C, et al. Free [NADH]/[NAD(+)] regulates sirtuin expression. Arch Biochem Biophys 2011; 512: 24-9.
141. Berchtold MW, Brinkmeier H, Muntener M. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 2000; 80: 1215-65.
142. Reid MB. Invited Review: redox modulation of skeletal muscle contraction: what we know and what we don't. J Appl Physiol 2001; 90: 724-31.
143. Salminen A, Vihko V. Endurance training reduces the susceptibility of mouse skeletal muscle to lipid peroxidation in vitro. Acta Physiol Scand 1983; 117: 109-13.
144. Gomez-Cabrera MC, Domenech E, Romagnoli M, et al. Oral administration of vitamin C decreases muscle mitochondrial biogene sis and hampers training-induced adaptations in endurance performance. Am J Clin Nutr 2008; 87: 142-9.
145. Ristow M, Zarse K, Oberbach A, et al. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 2009; 106: 8665-70.
146. Borras C, Gomez-Cabrera MC, Vina J. The dual role of p53: DNA protection and antioxidant. Free Radic Res 2011; 45: 643-52.
147. Huang LE, Arany Z, Livingston DM, et al. Activation of hypoxiainducible transcription factor depends primarily upon redoxsensitive stabilization of its alpha subunit. J Biol Chem 1996; 271: 32253-9.
148. Palomero J, Broome CS, Rasmussen P, et al. Heat shock factor activation in human muscles following a demanding intermittent exercise protocol is attenuated with hyperthermia. Acta Physiol (Oxf) 2008; 193: 79-88.
149. Ji LL. Exercise-induced modulation of antioxidant defense. Ann N Y Acad Sci 2002; 959: 82-92.
150. Vasilaki A, McArdle F, Iwanejko LM, et al. Adaptive responses of mouse skeletal muscle to contractile activity: The effect of age. Mech Ageing Dev 2006; 127: 830-9.
151. Williamson D, Gallagher P, Harber M, et al. Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle. J Physiol 2003; 547: 977-87.
152. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 1986; 47: 921-8.
153. Cai D, Frantz JD, Tawa NE, Jr., et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004; 119: 285-98.
154. Yu BP, Chung HY. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 2006; 127: 436-43.
155. Puigserver P, Wu Z, Park CW, et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998; 92: 829-39.
156. Gomez-Cabrera MC, Sanchis-Gomar F, Garcia-Valles R, et al. Mitochondria as sources and targets of damage in cellular aging. Clin Chem Lab Med 2012; 50: 1287-95.
157. Derbre F, Gomez-Cabrera MC, Nascimento AL, et al. Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1alpha to exercise training. Age (Dordr) 2011; 34: 669-79.
158. Vigen R, Maddox TM, Allen LA. Aging of the United States Population: Impact on Heart Failure. Curr Heart Fail Rep 2012.
159. Abbatecola AM, Fumagalli A, Bonardi D, et al. Practical management problems of chronic obstructive pulmonary disease in the elderly: acute exacerbations. Curr Opin Pulm Med 2011; 17 Suppl 1: S49-54.
160. Demontiero O, Vidal C, Duque G. Aging and bone loss: new insights for the clinician. Ther Adv Musculoskelet Dis 2012; 4: 61-76.
161. Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev 2005; 31: 380-402.
162. Caspersen CJ, Thomas GD, Boseman LA, et al. Aging, diabetes, and the public health system in the United States. Am J Public Health 2012; 102: 1482-97.
163. Pimenta E, Oparil S. Management of hypertension in the elderly. Nat Rev Cardiol 2012; 9: 286-96.
164. Pescatello LS, Franklin BA, Fagard R, et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36: 533-53.
165. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1423-34.
166. Goodyear LJ. The exercise pill--too good to be true? N Engl J Med 2008; 359: 1842-4.
167. Wojtaszewski JF, Nielsen P, Hansen BF, et al. Isoform-specific and exercise intensity-dependent activation of 5'-AMP-activated protein kinase in human skeletal muscle. J Physiol 2000; 528 Pt 1: 221-6.
168. Winder WW, Taylor EB, Thomson DM. Role of AMP-activated protein kinase in the molecular adaptation to endurance exercise. Med Sci Sports Exerc 2006; 38: 1945-9.
169. Narkar VA, Downes M, Yu RT, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008; 134: 405-15.
170. Reznick RM, Zong H, Li J, et al. Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab 2007; 5: 151-6.
171. Thomson DM, Brown JD, Fillmore N, et al. AMP-activated protein kinase response to contractions and treatment with the AMPK activator AICAR in young adult and old skeletal muscle. J Physiol 2009; 587: 2077-86.
172. Sanchis-Gomar F, Gomez-Cabrera MC, Vina J. The loss of muscle mass and sarcopenia: Non hormonal intervention. Exp Gerontol 2011.
173. Baur JA. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev; 131: 261-9.
174. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: 1109-22.
175. Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays agerelated deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008; 8: 157-68.
176. Barger JL, Kayo T, Vann JM, et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 2008; 3: e2264.
177. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 2009; 297: H1876-81.
178. Anderson R, Prolla T. PGC-1alpha in aging and anti-aging interventions. Biochim Biophys Acta 2009; 1790: 1059-66.
179. Jackson JR, Ryan MJ, Alway SE. Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J Gerontol A Biol Sci Med Sci; 66: 751-64.
180. O'Donovan G, Blazevich AJ, Boreham C, et al. The ABC of Physical Activity for Health: a consensus statement from the British Association of Sport and Exercise Sciences. J Sports Sci 2010; 28: 573-91.